The Sumatriptan and Naratriptan Pregnancy Registry

Trial Profile

The Sumatriptan and Naratriptan Pregnancy Registry

Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2015

At a glance

  • Drugs Naproxen sodium/sumatriptan (Primary) ; Naratriptan (Primary) ; Sumatriptan (Primary)
  • Indications Migraine
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 14 Nov 2011 Status changed from active, no longer recruiting to recruiting as reported by
    • 14 Nov 2011 Planned patient number is 1 according to
    • 06 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top